Radiofrequency catheter ablation of frequent premature ventricular contractions using ARRAY multi-electrode balloon catheter by Dubner, Sergio et al.
Address for correspondence: Sergio J. Dubner, MD, FACC, Director Arrhythmias and Electrophysiology Service,  
Clinica y Maternidad Suizo Argentina and De Los Arcos Sanatorio, Arenales 2463, 3 A, 1124 Buenos Aires, Argentina,  
tel: (+5411) 4827 3654, e-mail: sdubner@cardiologyjournal.org
Received: 29.06.2015 Accepted: 01.09.2015
Radiofrequency catheter ablation of frequent  
premature ventricular contractions using  
ARRAY multi-electrode balloon catheter
Sergio Dubner, Claudio Hadid, Damian Azocar, Carlos Labadet,  
Cecilia Valsecchi, Agustin Dominguez
Cardiology Department, Arrhythmias and Electrophysiology Service,  
Clinica y Maternidad Suizo Argentina, Buenos Aires, Argentina
Abstract
Background: The noncontact mapping system facilitates the mapping of premature ventricu-
lar contractions (PVCs) and ventricular tachycardia (VT) using a 64-electrode expandable 
balloon catheter (ARRAY, St. Jude Medical). The aim of this study is to analyze the results and 
follow-up of the PVC ablation using this system.
Methods and results: Prospective and consecutive patients with frequent PVCs (6,000 or 
more) or monomorphic VT, suspected to be originated on the right ventricular outflow tract 
(RVOT), were included. The balloon catheter was positioned in the RVOT. Eighteen patients, 
9 women, mean age 48 years (youngest/oldest 19–65) were included. Sixteen patients presented 
no structural heart disease. The origin of the arrhythmia was RVOT (n = 15), right ventricu-
lar inflow tract (n = 1), and left ventricular outflow tract (n = 2). Acute success was achieved 
in 15 patients; in 2 patients radiofrequency was not applied due to security reasons (origin 
site close to left coronary artery origin). The mean follow-up was 15 months (min. 4, max. 26);  
13 patients presented abolition of the arrhythmia without drugs and 1 patient required anti-
arrhythmic drugs for arrhythmia control (previously ineffective). As an only complication,  
a femoral artery-venous fistula was observed.
Conclusions: The noncontact mapping system using a multielectrode balloon allows right 
ventricular arrhythmia treatment with a high rate of efficacy and safety. (Cardiol J 2016; 23, 
1: 17–22)
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Editorial p. 1
Introduction
Premature ventricular contractions (PVCs) 
and ventricular tachycardia (VT) originating on 
the right ventricular outflow tract (RVOT) repre-
sent the most frequent ventricular arrhythmias in 
patients with normal hearts. VT from the RVOT’s 
origin constitutes 80% of the idiopathic VT [1, 2].
Sustained, fast and repetitive VT can cause 
palpitations, syncope or other symptoms. Repeti-
tive forms can lead to ventricular dysfunction [3]. 
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PVCs may be asymptomatic or present as palpita-
tions. Irrespective of symptoms, patients with very 
frequent PVCs (> 10–15% of beats), can develop 
ventricular dilation with impaired systolic function, 
a form of non-ischemic dilated cardiomyopathy.
Drug therapy, mainly beta-blockers and cal-
cium channel blockers, has limited effectiveness 
(25–50%) in arrhythmia suppression. Other anti-
arrhythmic drugs, such as propafenone, flecainide 
and specially amiodarone, have better outcome but 
are associated with side effects. For this reason, 
radiofrequency ablation (RFA) is increasingly being 
used in these patients [4, 5] and has been suggested 
by some authors as first-line therapy due to its high 
success and low complication rate [5, 6].
Electroanatomic mapping systems are widely 
used to treat these arrhythmias. With this tool, an 
activation map is created by plotting local activation 
times using a color-coding scale. To do this, the 
chamber of interest (in this case right ventricle) 
must be explored moving the mapping catheter 
and collecting the local ventricular electrograms 
point by point once PVC occurs. Therefore, it 
requires the presence of frequent PVCs and/or 
prolonged episodes of VT to achieve an accurate 
mapping of the arrhythmia. Despite using this 
technology, ablation may not be successful in cases 
of infrequent PVCs, non-inducible or hemodynami-
cally poorly tolerated arrhythmias in the labora-
tory. The non-contact mapping system (NCMS) is 
a self-expandable balloon catheter with 64 elec-
trodes (Fig. 1), which allows simultaneous acquir-
ing more than 3,000 virtual unipolar electrograms. 
Thus, mapping of arrhythmias with a single heart-
beat can be performed [7, 8]. There are limited data 
on outcomes in patients undergoing NCMS-guided 
RVOT ventricular arrhythmia ablation.
The aim of the study is to analyze the results 
and follow-up of radiofrequency catheter ablation in 
patients with PVCs and VT originating from RVOT 
with this technology.
Methods
Prospective and consecutive patients with fre-
quent PVCs or monomorphic VT evaluated in our 
institution were included. Inclusion criteria were 
monomorphic PVCs > 6,000/24 h or monomorphic 
VT, with left bundle branch block morphology on 
12-lead electrocardiogram (ECG) or 12-lead Holter 
recording and suspected origin at RVOT, scheduled 
for catheter ablation due to frequent symptoms, 
refractoriness or intolerance to antiarrhythmic 
drugs, or patient preference.
The balloon catheter (EnSite Array, St. Jude 
Medical, St. Paul, Minnesota, USA) was intro-
duced via the right femoral vein through a 10 Fr 
introducer and under fluoroscopic view over 
a 0.35’’ wire that had been placed in the pulmo-
nary artery. The deflated balloon (low profile) was 
advanced “over-the-wire” to the RVOT. Patients 
were heparinized in order to achieve an activated 
clotting time target between 300 s and 400 s. Once 
positioned in the RVOT, the balloon was inflated 
(high profile) and filled with iodinated contrast for 
radiological visualization (Fig. 1). Subsequently, 
the 3-dimensional geometry of the right ventricle 
Figure 1. Balloon catheter in the right ventricular out-
flow tract, high profile filled with iodide contrast to al-
low X-ray view; A. Left anterior oblique view; B. Right 
anterior oblique view.
A
B
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was acquired using the ablation catheter. Impor-
tant anatomic structures, such as the His bundle 
and pulmonary valve were identified and labeled. 
An activation map was created based on recorded 
balloon catheter unipolar electrograms from spon-
taneous PVCs that matched the clinical arrhythmia. 
Identification of the site of earliest activation (EA) 
as well as the output of the activation front to the 
rest of myocardium (break out [BO]) was obtained 
with one single beat. This process was repeated 
with another 3 PVCs to confirm the reproducibility 
of the map (Fig. 2).
General anesthesia was used in some cases. 
Due to its intrinsic effect to reduce or even abol-
ish ectopic activity, in some cases we used mild 
sedation or local anesthesia only if the patient con-
sented. Isoproterenol or programmed ventricular 
stimulation was used in patients without sponta-
neous arrhythmia during the procedure. To avoid 
arrhythmia induction caused by contact with the 
endocardium, all other catheters were withdrawn 
to the right atrium at the time of arrhythmia map-
ping. 12-lead concordance between the PVCs/VT 
recorded in the laboratory and those presented in 
the daily clinic was carefully assessed.
Then, unipolar electrograms from the multi-
electrode balloon catheter were used to identify 
the site of origin of the arrhythmia and visualize 
the spread of the electrical impulse from the EA 
to BO and then to the rest of the myocardium. The 
focus origin was determined by the QS pattern in 
the unipolar electrograms obtained with the balloon 
catheter. A QS pattern on a unipolar electrogram 
identifies the start depolarization site, from which 
the activation front centrifugally spreads away.
Radiofrequency application was addressed to 
both the EA and the BO points using 4 mm non-
irrigated tip catheter (50 W, 60∞C) with applications 
of 60 s until abolition of the arrhythmia. If a second 
focus of arrhythmia was observed after the first 
focus was targeted, a similar identification process 
and ablation was performed.
Acute success was defined as the sustained 
disappearance (total abolition) for at least 30 min of 
the spontaneous PVCs/VT or the reduction greater 
than 99%. The occurrence of the arrhythmia after 
this period was considered recurrence. Failure in 
abolishing the arrhythmia was considered as acute 
failure of the procedure.
Patients remained hospitalized until the next 
morning in coronary care unit with continuous ECG 
recording and a transthoracic echocardiography 
was performed before and after the intervention.
During the follow-up all patients were evalu-
ated every 15/30 days (first 2 months) and every 
4 months later, with routinely clinical controls, 
ECG and 24-h Holter recording during the first 
year after the procedure.
The study was approved by the local bioethi-
cal committee and all patients signed an informed 
consent.
Results
Between February 2012 and December 2014, 
18 patients (9 women) with a mean age of 48 years 
Figure 2. Right ventricular outflow tract’s activation map where earliest activation (EA) is observed following myocar-
dial activation (BO, break out). Yellow arrows show the balloon catheter.
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(min. 19, max. 65) were included. Only 2 patients 
had structural heart disease (nonischemic dilated 
cardiomyopathy and coronary artery disease). 
Most patients had frequent PVCs (≥ 6,000/24 h), 
4 (25%) patients presented non sustained VT 
and 3 patients presented sustained monomorphic 
VT. The average arrhythmic density before the 
procedure was 12,350 PVCs/24 h (min. 6,366, 
max. 25,671). The mean number of unsuccessful 
antiarrhythmic drugs used per patient was 1.4 
(min. 0, max. 5). In 4 patients, the RFA was the 
first-line treatment due to patients’ choice. The 
arrhythmia focus was identified in the RVOT in 
15 (83%) patients and right ventricular inflow tract 
in 1 patient. In the remaining 2 patients, the origin 
was identified in the left ventricular outflow tract 
near the origin of the left coronary artery; in both 
of them radiofrequency was not applied for safety 
reasons. Acute success, measured with abolition 
of the arrhythmia and the absence of symptoms, 
was achieved in 15/16 (93.7%) patients in whom 
radiofrequency was delivered (1 failure) and in all 
but 3 of the total number of patients (15/18, 83%). 
In 5 patients, 2 or more ventricular ectopic foci 
were found and ablated in the RVOT. In the patient 
with failed RFA, the focus was identified at the 
interventricular septum and radiofrequency was 
delivered from both sides (right and left) with no 
change in arrhythmia burden.
The average procedure time was 186 min (min. 
120, max. 240) and mean fluoroscopy time was 
37 min (min. 21, max. 59). There were no acute hemo - 
dynamic procedure complications and all patients 
were discharged within 24 h. Two patients presented 
incomplete right bundle branch block that persisted 
during the follow-up. One patient developed a femo-
ral artero-venous fistula, with surgical resolution.
During the follow-up (average 15 months, 
min. 4, max. 26) 13 of 16 patients in whom radio-
frequency was delivered (81%) were free from both 
arrhythmia and symptoms in a drug-free state. Two 
patients with acute RFA success had arrhythmia 
recurrence that was controlled with sotalol (previ-
ously ineffective) in one patient and with a second 
ablation procedure in the other patient. The patient 
with failed RFA was kept on antiarrhythmic drugs 
during the follow up, with poor response.
Discussion
The main result of this series is the high 
success rate and safety of NCMS in the patient 
population with outflow tract ventricular arrhyth-
mia. Acute success was achieved in 93.7% of pa-
tients in whom radiofrequency was delivered with 
1 complication (femoral artero-venous fistula). Dur-
ing the follow-up (average 15 months) 13 patients 
were free from arrhythmia without antiarrhythmic 
drug therapy and only 2 patients with acute success 
had recurrence. In 1 patient, the ablation procedure 
appears to have modified the arrhythmia substrate 
since PVC burden could be controlled by previously 
ineffective antiarrhythmic drugs. This may be inter-
preted as partially successful ablation.
The mapping of the arrhythmia focus with 
a single heartbeat deserves a special comment. 
Activation maps from 3 additional PVCs were per-
formed to confirm the focus location. This means 
that with less than 5 PVCs the target for ablation 
can be successfully identified, without need for 
a point-by-point mapping of the RVOT. Together 
with the high success rate of the RFA, this finding 
suggests the high accuracy of this technique for 
identification of the target site for ablation.
These results highlight the importance of pa-
tient selection for the use of this system. The best 
candidates are those with suspected origin in the 
RVOT (left bundle branch block morphology, infe-
rior frontal axis, R/S transition > V3) [9, 10]. This 
system has also been used in other right ventricle 
sites (right ventricular inflow tract in case number 6 
of our series), as well as in right atrium [11], left 
atrium [10] and even in the left ventricle [12]. The 
high effectiveness of this system in our series is in 
concordance with other published studies [12–15]. 
Tsuchiya [12] have reported the use of the NCMS 
in 55 patients with ventricular arrhythmia. The 
RVOT was the most frequent location of origin and 
successful ablation achieved in all but 3 patients 
with epicardial origin. Friedman et al. [14] have 
reported the success of ablation in 9 of 10 patients 
with non-inducible VT originating from the RVOT. 
Ling et al. [16] reported superiority of RFA over 
antiarrhythmic medication in arrhythmia suppres-
sion in patients with RVOT PVCs, in a prospective 
randomized study. Zhang et al. [17] found NCMS-
-guided RVOT catheter ablation highly effective, 
and clinical success was best achieved by ablating 
the EA site, rather than BO site.
Improvement of ejection fraction is another 
benefit after ventricular arrhythmias disappear. 
In the meta-analysis performed by Lamba et al. 
[18], left ventricular ejection fraction (LVEF) was 
reported in 5 of the 14 studies evaluated, which 
included 108 patients. Radiofrequency catheter 
ablation significantly improved LVEF by a mean of 
10.36 (confidence interval 8.75–11.97, p < 0.00001) 
in patients with frequent PVCs from the RVOT.
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Despite the efficacy of this system, there are 
some limitations to this technique. The progres-
sion of the guidewire and the deflated balloon to 
the pulmonary artery is not a simple task and may 
require a significant fluoroscopy time. In our case 
it was possible to successfully carry out such ma-
neuver in every patient, but in some cases it took 
up to 30 min. We observed a reduction of total and 
fluoroscopy times when comparing recent cases 
with the initial ones (learning curve) [19]. Another 
limitation of the method is related to the distance 
between the central axis of the balloon catheter and 
the focus of the arrhythmia. When the distance be-
tween them is greater than 4 cm (137⁄64 inches), the 
confidence of the activation map is impaired, and 
chances of applying radiofrequency in a wrong site 
are higher, and hence, efficiency is reduced. This 
is particularly important in arrhythmias originating 
in sites other than the RVOT (left ventricle, other 
areas of the right ventricle). To avoid this problem 
it is essential a deepest evaluation of the 12-lead 
ECG while planning the procedure. In one of our 
cases it was noted that the focus was located in the 
region of the tricuspid valve, so we pulled-down the 
balloon catheter closer to the arrhythmia focus, to 
ablate the basal region of the right ventricle. An-
other limitation of the method is the contact of the 
catheter balloon with the endocardium in certain 
circumstances, especially when using isoproter-
enol. It may generate an ectopic activity different 
from the clinical one. Despite the considerable 
size of the inflated balloon catheter, we have not 
observed any hemodynamic side effect. Schneider 
et al. [20] found similar results in 20 consecutive 
pediatric patients with idiopathic VT. The region of 
origin was identified in all of them, and the site of 
earliest activation with a QS pattern of the unipolar 
electrograms was guided for ablation. The authors 
concluded that noncontact mapping can safely and 
effectively be used to map and guide catheter abla-
tion of the tachycardia substrate of idiopathic VT 
in pediatric patients. Finally, the higher cost than 
other mapping systems is an important issue to be 
taken into account.
Limitations of the study
The small sample size and the rigorous patient 
selection may not be representative of rare forms 
of these arrhythmias (i.e. epicardial origin) or the 
occurrence of rare complications [19]. Since it is 
a single-center study, we cannot compare this 
result with different groups.
In 5 patients, we identified more than one fo-
cus of origin of the PVCs. However, radiofrequency 
applications can generate small shifts in arrhythmia 
exit sites and/or spread of electrical activation.
Conclusions
Noncontact mapping system with multielec-
trode balloon catheter allows an excellent and 
precise identification of the site of origin of the 
right ventricular arrhythmia. This mapping method 
allows obtaining a high rate of effectiveness of the 
ablation procedure, with high safety. Further stud-
ies with more patients and the comparison with 
antiarrhythmic drugs and other forms of catheter 
mapping can confirm these findings.
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